Spinal Cord Injury Causes Prominent Tau Pathology Associated with Brain Post-Injury Sequela
- PMID: 35501632
- DOI: 10.1007/s12035-022-02843-1
Spinal Cord Injury Causes Prominent Tau Pathology Associated with Brain Post-Injury Sequela
Abstract
Spinal cord injury (SCI) can result in significant neurological impairment and functional and cognitive deficits. It is well established that SCI results in focal neurodegeneration that gradually spreads to other cord areas. On the other hand, traumatic brain injury (TBI) is strongly associated with tau protein pathology and neurodegeneration that can spread in areas throughout the brain. Tau is a microtubule-associated protein abundant in neurons and whose abnormalities result in neuronal cell death. While SCI and TBI have been extensively studied, there is limited research on the relationship between SCI and brain tau pathology. As a result, in this study, we examined tau pathology in spinal cord and brain samples obtained from severe SCI mouse models at various time points. The effects of severe SCI on locomotor function, spatial memory, anxiety/risk-taking behavior were investigated. Immunostaining and immunoblotting confirmed a progressive increase in tau pathology in the spinal cord and brain areas. Moreover, we used electron microscopy to examine brain samples and observed disrupted mitochondria and microtubule structure following SCI. SCI resulted in motor dysfunction, memory impairment, and abnormal risk-taking behavior. Notably, eliminating pathogenic cis P-tau via systemic administration of appropriate monoclonal antibodies restored SCI's pathological and functional consequences. Thus, our findings suggest that SCI causes severe tauopathy that spreads to brain areas, indicating brain dysfunction. Additionally, tau immunotherapy with an anti-cis P-tau antibody could suppress pathogenic outcomes in SCI mouse models, with significant clinical implications for SCI patients. SCI induces profound pathogenic cis p-tau, which diffuses into the brain through CSF, resulting in brain neurodegeneration and cognitive decline.
Keywords: Cis P-tau; Cognitive decline; Monoclonal antibody; Pin1; Spinal cord injury; Traumatic brain injury.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Tau Pathology Triggered by Spinal Cord Injury Can Play a Critical Role in the Neurotrauma Development.Mol Neurobiol. 2020 Nov;57(11):4845-4855. doi: 10.1007/s12035-020-02061-7. Epub 2020 Aug 18. Mol Neurobiol. 2020. PMID: 32808121 Review.
-
Active immunotherapy against pathogenic Cis pT231-tau suppresses neurodegeneration in traumatic brain injury mouse models.Neuropeptides. 2022 Dec;96:102285. doi: 10.1016/j.npep.2022.102285. Epub 2022 Sep 3. Neuropeptides. 2022. PMID: 36087426
-
Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy.Nature. 2015 Jul 23;523(7561):431-436. doi: 10.1038/nature14658. Epub 2015 Jul 15. Nature. 2015. PMID: 26176913 Free PMC article.
-
Delayed microglial depletion after spinal cord injury reduces chronic inflammation and neurodegeneration in the brain and improves neurological recovery in male mice.Theranostics. 2020 Sep 14;10(25):11376-11403. doi: 10.7150/thno.49199. eCollection 2020. Theranostics. 2020. PMID: 33052221 Free PMC article.
-
Mouse closed head traumatic brain injury replicates the histological tau pathology pattern of human disease: characterization of a novel model and systematic review of the literature.Acta Neuropathol Commun. 2021 Jun 29;9(1):118. doi: 10.1186/s40478-021-01220-8. Acta Neuropathol Commun. 2021. PMID: 34187585 Free PMC article.
Cited by
-
MiR-10b-5p attenuates spinal cord injury and alleviates LPS-induced PC12 cells injury by inhibiting TGF-β1 decay and activating TGF-β1/Smad3 pathway through PTBP1.Eur J Med Res. 2024 Nov 19;29(1):554. doi: 10.1186/s40001-024-02133-7. Eur J Med Res. 2024. PMID: 39558432 Free PMC article.
-
Targeting cis-p-tau and neuro-related gene expression in traumatic brain injury: therapeutic insights from TC-DAPK6 treatment in mice.Mol Biol Rep. 2024 Sep 25;51(1):1010. doi: 10.1007/s11033-024-09945-0. Mol Biol Rep. 2024. PMID: 39320385
-
Intersection of hippocampus and spinal cord: a focus on the hippocampal alpha-synuclein accumulation, dopaminergic receptors, neurogenesis, and cognitive function following spinal cord injury in male rats.BMC Neurosci. 2022 Jul 12;23(1):44. doi: 10.1186/s12868-022-00729-5. BMC Neurosci. 2022. PMID: 35820831 Free PMC article.
References
-
- Ackery A, Tator C, Krassioukov A (2004) A global perspective on spinal cord injury epidemiology. J Neurotrauma 21(10):1355–1370. https://doi.org/10.1089/neu.2004.21.1355 - DOI - PubMed
-
- Van den Berg ME, Castellote JM, Mahillo-Fernandez I, de Pedro-Cuesta J (2010) Incidence of spinal cord injury worldwide: a systematic review. Neuroepidemiology 34(3):184–192. https://doi.org/10.1159/000279335 - DOI - PubMed
-
- Singh A, Tetreault L, Kalsi-Ryan S, Nouri A, Fehlings MG (2014) Global prevalence and incidence of traumatic spinal cord injury. Clin Epidemiol 6:309–331. https://doi.org/10.2147/CLEP.S68889 - DOI - PubMed - PMC
-
- Collins-Praino LE, Corrigan F (2017) Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury? Brain Behav Immun 60:369–382. https://doi.org/10.1016/j.bbi.2016.09.027 - DOI - PubMed
-
- Bethea JR, Dietrich WD (2002) Targeting the host inflammatory response in traumatic spinal cord injury. Curr Opin Neurol 15(3):355–360. https://doi.org/10.1097/00019052-200206000-00021 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous